Novoprotein Scientific Slides 13% Amid Sector-Wide Sell-Off: What It Means for Investors
Novoprotein Scientific slides 13% amid a biotech sell‑off, with weak volume and 200‑day SMA warnings—investors face regulatory, competitive, and liquidity headwinds.
3 minutes to read